Dr. Arianne Danielle Bennett-Venner, MD

Dr. Bennett-Venner practices at Pulmonary Practice Associates MD PA in Orange City, Florida.

Dr. Bennett-Venner's NPI, 1205084175, was assigned on September 4, 2008. Dr. Bennett-Venner graduated from University of the West Indies Faculty of Medicine in 1999. Dr. Bennett-Venner's Alabama license number on file is MD.31573.

Dr. Bennett-Venner's primary practice is Pulmonary Practice Associates MD PA, at 1075 Town Center Dr, Orange City, FL 32763 in Volusia County. The practice phone is (386) 917-0333.

Dr. Bennett-Venner's primary practice is Pulmonary Practice Associates MD PA in Orange City, Florida. Dr. Bennett-Venner is also affiliated with AdventHealth Fish Memorial. The medical group on file is Pulmonary Practice Associates. Dmand AI also links Dr. Bennett-Venner to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bennett-Venner practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Bennett-Venner's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Bennett-Venner is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Bennett-Venner's licenses on file in 3 states: Alabama, Florida and New Jersey.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pleural effusion, pulmonary heart disease, sleep apnea and tobacco use among the conditions Dr. Bennett-Venner treats.

CMS data shows 2,608 Medicare services from Dr. Bennett-Venner across 15 procedure codes in 2024, for 668 Medicare patients. Medicare paid $263,622 for them.

CMS counts 668 Medicare patients who saw Dr. Bennett-Venner in 2024. The largest group is 75 to 84, with 275 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bennett-Venner's median patient age at 71, with 50% women.

In 2024, Dr. Bennett-Venner wrote 1,502 Medicare Part D claims for 256 patients. 50% of them were for generic drugs. CMS names the drug for 1,384 of them, across 22 drugs with 11 or more claims each, at $406,730 in total drug cost. In 2023, CMS named 1,324 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Bennett-Venner for performance year 2024, reported as part of a group. Dr. Bennett-Venner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bennett-Venner as offering telehealth.

Dmand AI links 1 paper to Dr. Bennett-Venner. Dr. Bennett-Venner's most frequent co-authors are Mohammad Hassan Alsumrain, MD, Alan J. Klukowicz, MD and Justin J. Pi, MD.

CMS Open Payments shows 467 general payments to Dr. Bennett-Venner from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. GlaxoSmithKline, LLC. paid the most, $1,712.

Dr. Bennett-Venner graduated from University of the West Indies Faculty of Medicine in 1999.

Dr. Bennett-Venner is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.